The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
DRES syndrome - DRESS-like reaction
Publications
The DRESS syndrome: the great clinical mimicker.
Pharmacotherapy. 2011;31(3):332
Jurado-Palomo J, Cabañas R, Prior N, Bobolea ID, Fiandor-Román AM, López-Serrano MC, Quirce S, Bellón T
Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports.
Journal of investigational allergology & clinical immunology. 2010;20(5):433-6
Piperacillin-tazobactam-induced drug hypersensitivity syndrome.
Cutis. 2006;77(6):353-7
Cabañas R, Muñoz L, López-Serrano C, Contreras J, Padial A, Caballero T, Moreno-Ancillo A, Barranco P
Hypersensitivity to piperacillin.
Allergy. 1998;53(8):819-20